nach oben

Erschienen in:

04.07.2021 | Original Article

Subgroups of patients undergoing chemotherapy with distinct cognitive fatigue and evening physical fatigue profiles

verfasst von: Lisa Morse, Kord M. Kober, Carol Viele, Bruce A. Cooper, Steven M. Paul, Yvette P. Conley, Marilyn Hammer, Jon D. Levine, Christine Miaskowski

Erschienen in: Supportive Care in Cancer | Ausgabe 12/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose was to model cognitive fatigue and evening physical fatigue together to determine subgroups of patients with distinct cognitive fatigue AND evening physical fatigue profiles. Once these profiles were identified, differences among the subgroups in demographic and clinical characteristics, co-occurring symptoms, and quality of life outcomes were evaluated.

Methods

Oncology patients (n = 1332) completed self-report measures of cognitive fatigue and evening physical fatigue, six times over two cycles of chemotherapy. Latent profile analysis, which combined the two symptom scores, was done to identify subgroups of patients with distinct cognitive fatigue AND evening physical fatigue profiles.

Results

Three distinct profiles (i.e., Low [20.5%], Moderate [39.6%], and High [39.6%]) were identified. Compared to the Low class, patients in the High class were younger, female, and more likely to live alone and had a higher comorbidity burden and a lower functional status. In addition, these patients had a higher symptom burden and a poorer quality of life.

Conclusion

Based on clinically meaningful cutoff scores, 80% of the patients in this study had moderate to high levels of both cognitive fatigue and evening physical fatigue. In addition, these patients experienced high levels of other common symptoms (e.g., anxiety, depression, sleep disturbance, and pain). These co-occurring symptoms and other modifiable characteristics associated with membership in the Moderate and High classes may be potential targets for individualized symptom management interventions.

Abrahams HJG, Gielissen MFM, Verhagen C, Knoop H (2018) The relationship of fatigue in breast cancer survivors with quality of life and factors to address in psychological interventions: a systematic review. Clin Psychol Rev 63:1–11PubMed

Adams RN, Mosher CE, Winger JG, Abonour R, Kroenke K (2018) Cancer-related loneliness mediates the relationships between social constraints and symptoms among cancer patients. J Behav Med 41:243–252PubMed

Al Maqbali M, Al Sinani M, Al Naamani Z, Al Badi K, Tanash MI (2021) Prevalence of fatigue in patients with cancer: a systematic review and meta-analysis. J Pain Symptom Manage 61:167–189PubMed

Atallah M, Cooper B, Munoz RF, Paul SM, Anguera J, Levine JD, Hammer M, Wright F, Chen LM, Melisko M, Conley YP, Miaskowski C, Dunn LB (2020) Psychological symptoms and stress are associated with decrements in attentional function in cancer patients undergoing chemotherapy. Cancer Nurs 43:402–410PubMed

Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG (2001) AUDIT: The alcohol use disorders identification test: guidelines for use in primary care. World Health Organization, Geneva

Berger AM, Mooney K, Alvarez-Perez A, Breitbart WS, Carpenter KM, Cella D, Cleeland C, Dotan E, Eisenberger MA, Escalante CP, Jacobsen PB, Jankowski C, LeBlanc T, Ligibel JA, Loggers ET, Mandrell B, Murphy BA, Palesh O, Pirl WF, Plaxe SC, Riba MB, Rugo HS, Salvador C, Wagner LI, Wagner-Johnston ND, Zachariah FJ, Bergman MA, Smith C, National comprehensive cancer n (2015) Cancer-Related Fatigue, Version 2.2015. J Natl Compr Cancer Netw 13:1012–1039

Bower JE (2019) The role of neuro-immune interactions in cancer-related fatigue: biobehavioral risk factors and mechanisms. Cancer 125:353–364PubMed

Chen YJ, Li XX, Ma HK, Zhang X, Wang BW, Guo TT, Xiao Y, Bing ZT, Ge L, Yang KH, Han XM (2020) Exercise training for improving patient-reported outcomes in patients with advanced-stage cancer: a systematic review and meta-analysis. J Pain Symptom Manage 59:734-749.e710PubMed

Cimprich B, So H, Ronis DL, Trask C (2005) Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer. Psychooncology 14:70–78PubMed

10.

Cimprich B, Visovatti M, Ronis DL (2011) The Attentional Function Index-a self-report cognitive measure. Psychooncology 20:194–202PubMed

11.

Daut RL, Cleeland CS, Flanery RC (1983) Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 17:197–210PubMed

12.

de Jong N, Candel MJ, Schouten HC, Abu-Saad HH, Courtens AM (2004) Prevalence and course of fatigue in breast cancer patients receiving adjuvant chemotherapy. Ann Oncol 15:896–905PubMed

13.

de Jong N, Candel MJ, Schouten HC, Abu-Saad HH, Courtens AM (2005) Course of mental fatigue and motivation in breast cancer patients receiving adjuvant chemotherapy. Ann Oncol 16:372–382PubMed

14.

de Jong N, Kester AD, Schouten HC, Abu-Saad HH, Courtens AM (2006) Course of fatigue between two cycles of adjuvant chemotherapy in breast cancer patients. Cancer Nurs 29:467–477PubMed

15.

de Raaf PJ, de Klerk C, van der Rijt CC (2013) Elucidating the behavior of physical fatigue and mental fatigue in cancer patients: a review of the literature. Psychooncology 22:1919–1929PubMed

16.

Dew IT, Buchler N, Dobbins IG, Cabeza R (2012) Where is ELSA? The early to late shift in aging. Cereb Cortex 22:2542–2553PubMed

17.

Dimsdale JE, Ancoli-Israel S, Ayalon L, Elsmore TF, Gruen W (2007) Taking fatigue seriously, II: variability in fatigue levels in cancer patients. Psychosomatics 48:247–252PubMed

18.

Dupont A, Bower JE, Stanton AL, Ganz PA (2014) Cancer-related intrusive thoughts predict behavioral symptoms following breast cancer treatment. Health Psychol 33:155–163PubMed

19.

Extermann M, Bonetti M, Sledge GW, O’Dwyer PJ, Bonomi P, Benson AB 3rd (2004) MAX2—a convenient index to estimate the average per patient risk for chemotherapy toxicity; validation in ECOG trials. Eur J Cancer 40:1193–1198PubMed

20.

Fletcher BS, Paul SM, Dodd MJ, Schumacher K, West C, Cooper B, Lee K, Aouizerat B, Swift P, Wara W, Miaskowski CA (2008) Prevalence, severity, and impact of symptoms on female family caregivers of patients at the initiation of radiation therapy for prostate cancer. J Clin Oncol 26:599–605PubMed

21.

Gupta D, Lis CG, Grutsch JF (2007) The relationship between cancer-related fatigue and patient satisfaction with quality of life in cancer. J Pain Symptom Manage 34:40–47PubMed

22.

Hamidou Z, Dabakuyo TS, Bonnetain F (2011) Impact of response shift on longitudinal quality-of-life assessment in cancer clinical trials. Expert Rev Pharmacoecon Outcomes Res 11:549–559PubMed

23.

Han Tatiana J, Felger Jennifer C, Lee Anna, Mister Donna, Miller Andrew H, Torres Mylin A (2016) Association of childhood trauma with fatigue, depression, stress, and inflammation in breast cancer patients undergoing radiotherapy. Psychooncology 25:187–193PubMed

24.

Henry DH, Viswanathan HN, Elkin EP, Traina S, Wade S, Cella D (2008) Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S. Support Care Cancer 16:791–801PubMed

25.

Huehnchen P, van Kampen A, Boehmerle W, Endres M (2020) Cognitive impairment after cytotoxic chemotherapy. Neurooncol Pract 7:11–21PubMed

26.

Hughes A, Suleman S, Rimes KA, Marsden J, Chalder T (2020) Cancer-related fatigue and functional impairment—towards an understanding of cognitive and behavioural factors. J Psychosom Res 134:110127PubMed

27.

Institute of Medicine (2012) Living well with chronic illness: a call for public health sction. In: Living Well with Chronic Illness: A Call for Public Health Action. The National Academies Press, Washington, DC

28.

Jacobs JM, Ream ME, Pensak N, Nisotel LE, Fishbein JN, MacDonald JJ, Buzaglo J, Lennes IT, Safren SA, Pirl WF, Temel JS, Greer JA (2019) Patient experiences with oral chemotherapy: adherence, symptoms, and quality of life. J Natl Compr Cancer Netw 17:221–228

29.

Jung JY, Lee JM, Kim MS, Shim YM, Zo JI, Yun YH (2018) Comparison of fatigue, depression, and anxiety as factors affecting posttreatment health-related quality of life in lung cancer survivors. Psychooncology 27:465–470PubMed

30.

Jung T, Wickrama KAS (2008) An introduction to latent class growth analysis and growth mixture modeling. Soc Personal Psychol Compass 2:302–317

31.

Karnofsky D (1977) Performance scale. Plenum Press, New York

32.

Kessels E, Husson O, van der Feltz-Cornelis CM (2018) The effect of exercise on cancer-related fatigue in cancer survivors: a systematic review and meta-analysis. Neuropsychiatr Dis Treat 14:479–494PubMedPubMedCentral

33.

Kim HJ, Barsevick AM, Fang CY, Miaskowski C (2012) Common biological pathways underlying the psychoneurological symptom cluster in cancer patients. Cancer Nurs 35:E1–E20PubMed

34.

Kuhlman KR, Chiang JJ, Horn S, Bower JE (2017) Developmental psychoneuroendocrine and psychoneuroimmune pathways from childhood adversity to disease. Neurosci Biobehav Rev 80:166–184PubMedPubMedCentral

35.

Lange M, Joly F, Vardy J, Ahles T, Dubois M, Tron L, Winocur G, De Ruiter MB, Castel H (2019) Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors. Ann Oncol 30:1925–1940PubMed

36.

Lee KA (1992) Self-reported sleep disturbances in employed women. Sleep 15:493–498PubMed

37.

Lee KA, Hicks G, Nino-Murcia G (1991) Validity and reliability of a scale to assess fatigue. Psychiatry Res 36:291–298PubMed

38.

Liu L, Fiorentino L, Natarajan L, Parker BA, Mills PJ, Sadler GR, Dimsdale JE, Rissling M, He F, Ancoli-Israel S (2009) Pre-treatment symptom cluster in breast cancer patients is associated with worse sleep, fatigue and depression during chemotherapy. Psychooncology 18:187–194PubMedPubMedCentral

39.

Matura LA, Malone S, Jaime-Lara R, Riegel B (2018) A systematic review of biological mechanisms of fatigue in chronic illness. Biol Res Nurs 20:410–421PubMedPubMedCentral

40.

Miaskowski C, Cooper BA, Aouizerat B, Melisko M, Chen LM, Dunn L, Hu X, Kober KM, Mastick J, Levine JD, Hammer M, Wright F, Harris J, Armes J, Furlong E, Fox P, Ream E, Maguire R, Kearney N (2017) The symptom phenotype of oncology outpatients remains relatively stable from prior to through 1 week following chemotherapy. Eur J Cancer Care 26(3):e12437. https://doi.org/10.1111/ecc.12437CrossRef

41.

Miaskowski C, Cooper BA, Melisko M, Chen LM, Mastick J, West C, Paul SM, Dunn LB, Schmidt BL, Hammer M, Cartwright F, Wright F, Langford DJ, Lee K, Aouizerat BE (2014) Disease and treatment characteristics do not predict symptom occurrence profiles in oncology outpatients receiving chemotherapy. Cancer 120:2371–2378PubMed

42.

Mustian KM, Alfano CM, Heckler C, Kleckner AS, Kleckner IR, Leach CR, Mohr D, Palesh OG, Peppone LJ, Piper BF, Scarpato J, Smith T, Sprod LK, Miller SM (2017) Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis. JAMA Oncol 3:961–968PubMedPubMedCentral

43.

Muthen LK, Muthen BO (1998–2020) Mplus user’s guide, 8th edn. Muthen & Muthen, Los Angeles

44.

Nguyen TT, Lee EE, Daly RE, Wu TC, Tang Y, Tu X, Van Patten R, Jeste DV, Palmer BW (2020) Predictors of loneliness by age decade: study of psychological and environmental factors in 2,843 community-dwelling Americans aged 20–69 years. J Clin Psychiatry 81

45.

Padilla GV, Ferrell B, Grant MM, Rhiner M (1990) Defining the content domain of quality of life for cancer patients with pain. Cancer Nurs 13:108–115PubMed

46.

Pertl MM, Hevey D, Collier S, Lambe K, O’Dwyer AM (2014) Predictors of fatigue in cancer patients before and after chemotherapy. J Health Psychol 19:699–710PubMed

47.

Puigpinos-Riera R, Serral G, Sala M, Bargallo X, Quintana MJ, Espinosa M, Manzanera R, Domenech M, Macia F, Grau J, Vidal E (2020) Cancer-related fatigue and its determinants in a cohort of women with breast cancer: the DAMA Cohort. Support Care Cancer 28:5213–5221PubMed

48.

Radbruch L, Strasser F, Elsner F, Gonçalves JF, Løge J, Kaasa S, Nauck F, Stone P (2008) Fatigue in palliative care patients — an EAPC approach. Palliat Med 22:13–32PubMed

49.

Radloff LS (1977) The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401

50.

Rau KM, Shun SC, Chiou TJ, Lu CH, Ko WH, Lee MY, Huang WT, Yeh KH, Chang CS, Hsieh RK (2020) A nationwide survey of fatigue in cancer patients in Taiwan: an unmet need. Jpn J Clin Oncol 50:693–700PubMedPubMedCentral

51.

Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN (2003) The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum 49:156–163PubMed

52.

Schmidt ME, Hermann S, Arndt V, Steindorf K (2020) Prevalence and severity of long‐term physical, emotional, and cognitive fatigue across 15 different cancer entities. Cancer Med 9:8053–8061PubMedPubMedCentral

53.

Schmidt ME, Wiskemann J, Schneeweiss A, Potthoff K, Ulrich CM, Steindorf K (2018) Determinants of physical, affective, and cognitive fatigue during breast cancer therapy and 12 months follow-up. Int J Cancer 142:1148–1157PubMed

54.

Singer S, Kuhnt S, Zwerenz R, Eckert K, Hofmeister D, Dietz A, Giesinger J, Hauss J, Papsdorf K, Briest S, Brown A (2011) Age- and sex-standardised prevalence rates of fatigue in a large hospital-based sample of cancer patients. Br J Cancer 105:445–451PubMedPubMedCentral

55.

Smets EM, Garssen B, Bonke B, De Haes JC (1995) The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39:315–325PubMed

56.

Spielberger CG, Gorsuch RL, Suchene R, Vagg PR, Jacobs GA (1983) Manual for the State-Anxiety (Form Y): Self Evaluation Questionnaire. Consulting Psychologists Press, Palo Alto

57.

Stein KD, Martin SC, Hann DM, Jacobsen PB (1998) A multidimensional measure of fatigue for use with cancer patients. Cancer Pract 6:143–152PubMed

58.

Thong MSY, Mols F, van de Poll-Franse LV, Sprangers MAG, van der Rijt CCD, Barsevick AM, Knoop H, Husson O (2018) Identifying the subtypes of cancer-related fatigue: results from the population-based PROFILES registry. J Cancer Surviv 12:38–46PubMed

59.

Tsaras K, Papathanasiou IV, Mitsi D, Veneti A, Kelesi M, Zyga S, Fradelos EC (2018) Assessment of depression and anxiety in breast cancer patients: prevalence and associated factors. Asian Pac J Cancer Prev 19:1661–1669PubMedPubMedCentral

60.

Ware J, Kosinski M, Keller SD (1996) A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34:220–233PubMed

61.

Wildiers H, Heeren P, Puts M, Topinkova E, Janssen-Heijnen ML, Extermann M, Falandry C, Artz A, Brain E, Colloca G, Flamaing J, Karnakis T, Kenis C, Audisio RA, Mohile S, Repetto L, Van Leeuwen B, Milisen K, Hurria A (2014) International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol 32:2595–2603PubMedPubMedCentral

62.

Williams AM, Khan CP, Heckler CE, Barton DL, Ontko M, Geer J, Kleckner AS, Dakhil S, Mitchell J, Mustian KM, Peppone LJ, Kipnis V, Kamen CS, O’Mara AM, Janelsins MC (2021) Fatigue, anxiety, and quality of life in breast cancer patients compared to non-cancer controls: a nationwide longitudinal analysis. Breast Cancer Res Treat 187(1):275–285. https://doi.org/10.1007/s10549-020-06067-6CrossRefPubMed

63.

Witek Janusek L, Tell D, Albuquerque K, Mathews HL (2013) Childhood adversity increases vulnerability for behavioral symptoms and immune dysregulation in women with breast cancer. Brain Behav Immun 30 Suppl:S149-162PubMed

64.

Wright F, Cooper BA, Conley YP, Hammer MJ, Chen LM, Paul SM, Levine JD, Miaskowski C, Kober KM (2017) Distinct evening fatigue profiles in oncology outpatients receiving chemotherapy Fatigue. Biomed Health Behav 5:131–144

65.

Wright F, D’Eramo Melkus G, Hammer M, Schmidt BL, Knobf MT, Paul SM, Cartwright F, Mastick J, Cooper BA, Chen LM, Melisko M, Levine JD, Kober K, Aouizerat BE, Miaskowski C (2015) Predictors and trajectories of morning fatigue are distinct from evening fatigue. J Pain Symptom Manage 50:176–189PubMedPubMedCentral

66.

Wright F, D’Eramo Melkus G, Hammer M, Schmidt BL, Knobf MT, Paul SM, Cartwright F, Mastick J, Cooper BA, Chen LM, Melisko M, Levine JD, Kober K, Aouizerat BE, Miaskowski C (2015) Trajectories of evening fatigue in oncology outpatients receiving chemotherapy. J Pain Symptom Manage 50:163–175PubMedPubMedCentral

67.

Wright F, Dunn LB, Paul SM, Conley YP, Levine JD, Hammer MJ, Cooper BA, Miaskowski C, Kober KM (2019) Morning fatigue severity profiles in oncology outpatients receiving chemotherapy. Cancer Nurs 42:355–364PubMedPubMedCentral

68.

Wright F, Hammer M, Paul SM, Aouizerat BE, Kober KM, Conley YP, Cooper BA, Dunn LB, Levine JD, Dem G, Miaskowski C (2017) Inflammatory pathway genes associated with inter-individual variability in the trajectories of morning and evening fatigue in patients receiving chemotherapy. Cytokine 91:187–210PubMedPubMedCentral

69.

Wright F, Hammer MJ, D’Eramo Melkus G (2014) Associations between multiple chronic conditions and cancer-related fatigue: an integrative review. Oncol Nurs Forum 41:399–410PubMed

Titel: Subgroups of patients undergoing chemotherapy with distinct cognitive fatigue and evening physical fatigue profiles
verfasst von: Lisa Morse
Kord M. Kober
Carol Viele
Bruce A. Cooper
Steven M. Paul
Yvette P. Conley
Marilyn Hammer
Jon D. Levine
Christine Miaskowski
Publikationsdatum: 04.07.2021
Verlag: Springer Berlin Heidelberg
Erschienen in: Supportive Care in Cancer / Ausgabe 12/2021
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-021-06410-7

Springer Medizin

Subgroups of patients undergoing chemotherapy with distinct cognitive fatigue and evening physical fatigue profiles